Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours

International Journal of Cancer

Volumn 118, Issue 2, 2006, Pages 346-352

  Lindsey, Janet C ^a   Lusher, Meryl E ^a   Strathdee, Gordon ^b   Brown, Robert ^b   Gilbertson, Richard J ^c   Bailey, Simon ^d   Ellison, David W ^a   Clifford, Steven C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

DNAJD1; Ependymoma; Hypermethylation; MCJ; Medulloblastoma; Primitive neuroectodermal tumour

Indexed keywords

PROTEIN DNAJ; PROTEIN DNAJD1; PROTEIN MCJ; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CPG ISLAND; DNA METHYLATION; EPENDYMOMA; EPIGENETICS; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE SILENCING; HUMAN; INFANT; MALE; MCJ GENE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; EPENDYMOMA; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE SILENCING; HSP40 HEAT-SHOCK PROTEINS; HUMANS; MALE; MEMBRANE PROTEINS; NEUROECTODERMAL TUMORS, PRIMITIVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 28844442769     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21353     Document Type: Article

References (36)

1. Giangaspero F, Bigner SH, Kleihues P, Pietsch T, Trojanowski JQ. Medulloblastoma. In: Kleihues P, Cavenee WK, eds. Tumours of the nervous system. Lyon: IARC, 2000.129-39.
2. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, Collins VP, Feuerstein BG. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 1999;86:331-9.
3. Vogel H, Fuller GN. Primitive neuroectodermal tumors, embryonal, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems. Ann Diagn Pathol 2003; 7:387-98.
4. Ellison D. Classifying the medulloblastoma: insights from morphology and molecular eenetics. Neuropathol Appl Neurobiol 2002;28: 257-82.
5. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancers. Nat Rev Genet 2002;3:415-28.
6. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004;429:457-63.
7. Fruhwald MC, O'Dorisio MS, Dai Z, Tanner SM, Balster DA, Gao X, Wright FA, Plass C. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastoma-implications for tumour biology and potential clinical utility. Oncogene 2001;20:5033-42.
8. Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF. Aberrant promoter methylation and silencing of the RASSFIA gene in pediatric tumours and cell lines. Oncogene 2002; 21:4345-9.
9. Harada K, Toyooka S, Shivapurkar N, Maitra A, Reddy JL, Matta H, Miyajima K, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Chaudhary PM, Gazdar AF. Deregulation of caspase 8 and 10 expression in paediatric tumours and cell lines. Cancer Res 2002;62:5897-901.
10. Lusher ME, Lindsey JC, Latif F, Pearson AD, Ellison DW, Clifford SC. Bi-allelic epigenetic inactivation of the RASSFIA gene in medulloblastoma development Cancer Res 2002;62:5906-11.
11. Rood BR, Zhang H, Weitman DM, Cogen PH. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res 2002; 62:3794-7.
12. Zuzak TJ, Steinhoff DF, Sutton LN, Phillips PC, Eggert A, Grotzer MA. Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. Eur J Cancer 2002;38:83-91.
13. Gonzalez-Gomez P, Bello MJ, Lomas J, Arjona D, Alonso ME, Aminoso C, De Campos JM, Vaquero J, Sarasa JL, Casartelli C, Rey JA. Epigenetic changes in pilocytic astrocytomas and medulloblastomas. Int J Mol Med 2003;11:655-60.
14. Waha A, Waha A, Koch A, Meyer-Puttlitz B, Weggen S, Sorensen N, Tonn JC, Albrecht S, Goodyer CG, Berthold F, Wiestler OD, Pietsch T. Epigenetic silencing of the HIC-1 gene in human medulloblastomas. J Neuropathol Exp Neurol 2003;62:1192-201.
15. Lindsey JC, Lusher ME, Anderton JA, Bailey S, Gilbertson RJ, Pearson AD, Ellison DW, Clifford SC. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling. Carcinogenesis 2004;25:661-8.
16. Shridhar V, Bible KC, Staub J, Avula R, Lee YK, Kalli K, Huang H, Hartmann LC, Kaufmann SH, Smith DI. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. Cancer Res 2001;61:4258-65.
17. Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Carcinogenesis 2004;25:693-701.
18. Kelley WL. The J-domain family and the recruitment of chaperone power. Trends Biochem Sci 1998;23:222-7.
19. Strathdee G, Vass JK, Oien KA, Siddiqui N, Curto-Garcia J, Brown R. Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy. Gynecol Oncol 2005;97:898-903.
20. He XM, Wikstrand CJ, Friedman HS, Bigner SH, Pleasure S, Trojanowski JQ, Bigner DD. Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts. Lab Invest 1991;64:833-43.
21. Keles GE, Berger MS, Srinivasan J, Kolstoc DD, Bobola MS, Silber JR. Establishment and characterisation of four human medulloblastoma-derived cell lines. Oncol Res 1995;7:493-503.
22. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-31.
23. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-4.
24. Horikoshi T, Danenberg KD, Stadlbauer TH, Volkenandt M, Shea LC, Aigner K, Gustavsson B, Leichman L, Frosing R, Ray M. Quantitation of thymidylate synthase, a dihydrofolate reductase, and DT-diaphorase gene expression in human tumours using the polymerase chain reaction. Cancer Res 1992;52:108-16.
25. Fults D, Pedone CA, Morse HG, Rose JW, McKay RD. Establishment and characterization of a human primitive neuroectodermal tumor cell line from the cerebral hemisphere. J Neuropathol Exp Neurol 1992; 51:272-80.
26. Ehrlich M, Jiang G, Fiala E, Dome JS, Yu MC, Long TI, Youn B, Sohn OS, Widschwendter M, Tomlinson GE, Chintagumpala M, Champagne M, et al. Hypomethylation and hypermethylation of DNA in Wilms' tumors. Oncogene 2002;21:6694-702.
27. Graff JR, Herman JG, Myohanen S, Baylin SB, Vertino PM. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 1997;272:22322-9.
28. Stirzaker C, Song JZ, Davidson B, Clark SJ. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modification in cancer cells. Cancer Res 2004;64:3871-7.
29. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-3.
30. Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, Perry R, Walker D, Gilbertson R, Ellison DW. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 2002;86:929-39.
31. Grierson AJ, Hodgkins MA, Hancock BW, Gospel JR, Royds J, Goyns MH. Investigation of the RB-I tumour suppressor gene in a United Kingdom series of non-Hodgkin's lymphomas. Leuk Lymphoma 1996;23:353-63.
32. Tamura K, Zhang X, Murakami Y, Hirohashi S, Xu HJ, Hu SX, Benedict WF, Sekiya T. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int J Cancer 1997;74:45-9.
33. Tsang YS, Lo KW, Leung SF, Choi PH, Fong Y, Lee JC, Huang DP. Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer 1999;83:305-8.
34. O'Connor DP, Kay EW, Leader M, Murphy GM, Atkins GJ, Mabruk MJ. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb. Mol Pathol 2001;54:165-9.
35. Shattuck TM, Kim TS, Costa J, Yandell DW, Imanishi Y, Palanisamy N, Gaz RD, Shoback D, Clark OH, Monchik JM, Wierman ME, Hollenberg A, et al. Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma. Clin Endocrinol 2003;59:180-9.
36. Kurzik-Dumke U, Gundacker D, Renthrop M, Gateff E. Tumor suppression in Drosophila is causally related to the function of the lethal(2) tumorous imaginal discs gene, a dnaJ homolog. Dev Genet 1995;16:64-76.